Plasma Bile Acids Are Associated with Energy Expenditure and Thyroid Function in Humans

2012 ◽  
Vol 97 (2) ◽  
pp. 535-542 ◽  
Author(s):  
Johann Ockenga ◽  
Luzia Valentini ◽  
Tatjana Schuetz ◽  
Franziska Wohlgemuth ◽  
Silja Glaeser ◽  
...  
Nature ◽  
2006 ◽  
Vol 439 (7075) ◽  
pp. 484-489 ◽  
Author(s):  
Mitsuhiro Watanabe ◽  
Sander M. Houten ◽  
Chikage Mataki ◽  
Marcelo A. Christoffolete ◽  
Brian W. Kim ◽  
...  

1998 ◽  
pp. 536-542 ◽  
Author(s):  
A Berghout ◽  
W Wiersinga

An analysis of all available studies of thyroid size and function in pregnancy reveals that thyroid size, estimated by inspection and palpation or measured more accurately by ultrasonography, increases in pregnancy in areas of iodine deficiency but not in those with sufficient iodine. The increase in average thyroid size is within the normal range, and can partly be prevented by treatment with extra iodine or thyroxine. There is a slight transient increase in free thyroxine in the first trimester, probably as a result of physiological stimulation of thyroid function by human choriogonadotrophin. These levels then decrease by about 30% to low normal values in the second and third trimesters of pregnancy in both iodine-depleted and -replete areas. These changes resemble those of non-thyroidal illness and may well play a role in reducing energy expenditure during pregnancy. The increase in thyroid size in iodine-deficient areas is probably due to autoregulatory mechanisms of iodine on thyroid growth. The hypothesis is supported by the fact that, during pregnancy, thyroid volume and thyroid function adapt in a physiological way to meet the increased demands for iodine and energy.


2014 ◽  
Vol 3 (4) ◽  
pp. 193-199 ◽  
Author(s):  
David P Sonne ◽  
Asger Lund ◽  
Jens Faber ◽  
Jens J Holst ◽  
Tina Vilsbøll ◽  
...  

Bile acids are possible candidate agents in newly identified pathways through which energy expenditure may be regulated. Preclinical studies suggest that bile acids activate the enzyme type 2 iodothyronine deiodinase, which deiodinates thyroxine (T4) to the biologically active triiodothyronine (T3). We aimed to evaluate the influence of bile acid exposure and incretin hormones on thyroid function parameters in patients with type 2 diabetes. Thyroid-stimulating hormone (TSH) and thyroid hormones (total T3 and free T4) were measured in plasma from two human studies: i) 75 g-oral glucose tolerance test (OGTT) and three isocaloric (500 kcal) and isovolaemic (350 ml) liquid meals with increasing fat content with concomitant ultrasonographic evaluation of gallbladder emptying in 15 patients with type 2 diabetes and 15 healthy age, gender and BMI-matched controls (meal-study) and ii) 50 g-OGTT and isoglycaemic intravenous glucose infusions (IIGI) alone or in combination with glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP1) and/or GLP2, in ten patients with type 2 diabetes (IIGI-study). In both studies, TSH levels declined (P<0.01) similarly following all meal and infusion stimuli. T3 and T4 concentrations did not change in response to any of the applied stimuli. TSH levels declined independently of the degree of gallbladder emptying (meal-study), route of nutrient administration and infusion of gut hormones. In conclusion, intestinal bile flow and i.v. infusions of the gut hormones, GIP, GLP1 and/or GLP2, do not seem to affect thyroid function parameters. Thus, the presence of a ‘gut–thyroid–pituitary’ axis seems questionable.


2013 ◽  
Vol 10 (2) ◽  
pp. 54-58 ◽  
Author(s):  
S M Zakharova ◽  
L V Savelieva ◽  
M I Fadeeva

Obesity and hypothyroidism are common diseases, and consequently clinicians should be particularly alert to the possibility of thyroid dysfunction in obese patients. The relationship between thyroid function and obesity is likely to be bidirectional, with hypothyroidism affecting weight, but obesity also influencing thyroid function. Both serum thyroid-stimulating hormone and fT3 are typically increased in obese individuals, an effect likely mediated by leptin. Following L-T4 treatment for overt hypothyroidism, weight loss appears to be modest and mediated primarily by loss of water weight rather than fat. Selected thyroid analogs might be a means by which to improve weight loss by increasing energy expenditure in obese patients during continued caloric deprivation


2021 ◽  
Author(s):  
Haixin Yin ◽  
Weijie Chen ◽  
Liangbo Dong ◽  
Shengnan Zhou ◽  
Qiang Qu ◽  
...  

Abstract Background and aims: Our aims were to investigate changes of bile acids and resting energy expenditure (REE) in patients with type 2 diabetes mellitus (T2DM) after laparoscopic cholecystectomy (LC) and the role in metabolic homeostasis.Methods: From December 2019 to May 2020, a total of 77 T2DM patients with gallbladder polyps were included in our study. Among them, 40 patients who underwent LC were enrolled into cholecystectomy group, 37 patients who did not undergo LC were enrolled into control group. Preoperative and 6-months postoperative demographic data, body weight, food intake, effects on diabetes control, and biomedical variables were recorded and compared.Results: The mean level of total bile acids (TBA) was higher than that in control group (P=0.033) and increased significantly after LC compared to baseline (P=0.029). The resting energy expenditure (REE) level in cholecystectomy group was higher than that in control group (P=0.032) and increased compared to the baseline (P=0.011). The utilization of carbohydrate increased significantly after LC (P<0.001) while the utilization of fat decreased (P<0.001). The mean level of FPG (P=0.004), A1C (P<0.001) and HOMA-IR (P=0.045) decreased after LC, as defined, the total effectiveness rate was 45%. The mean level of total cholesterol (P=0.003) and low-density lipoprotein cholesterol significantly decreased (P= 0.021), whereas the level of high-density lipoprotein cholesterol increased (P<0.001). Conclusions: The level of REE and TBA increased after LC in patients with T2DM, the glucose and lipid metabolism improved.Trial registration: Chinese Clinical Trial Registry, ChiCTR1900027823. Registered 30 November 2019, http://www.chictr.org.cn/index.aspx.


2000 ◽  
pp. 333-348 ◽  
Author(s):  
Jens Otto Lunde Jørgensen ◽  
Troels Wolthers ◽  
Jørgen Weeke

2017 ◽  
Vol 102 (7) ◽  
pp. 2533-2542 ◽  
Author(s):  
Mary H. Samuels ◽  
Irina Kolobova ◽  
Megan Antosik ◽  
Meike Niederhausen ◽  
Jonathan Q. Purnell ◽  
...  

Abstract Purpose: It is not clear whether upper limits of the thyrotropin (TSH) reference range should be lowered. This debate can be better informed by investigation of whether variations in thyroid function within the reference range have clinical effects. Thyroid hormone plays a critical role in determining energy expenditure, body mass, and body composition, and therefore clinically relevant variations in these parameters may occur across the normal range of thyroid function. Methods: This was a cross-sectional study of 140 otherwise healthy hypothyroid subjects receiving chronic replacement therapy with levothyroxine (L-T4) who had TSH levels across the full span of the laboratory reference range (0.34 to 5.6 mU/L). Subjects underwent detailed tests of energy expenditure (total and resting energy expenditure, thermic effect of food, physical activity energy expenditure), substrate oxidation, diet intake, and body composition. Results: Subjects with low-normal (≤2.5 mU/L) and high-normal (&gt;2.5 mU/L) TSH levels did not differ in any of the outcome measures. However, across the entire group, serum free triiodothyronine (fT3) levels were directly correlated with resting energy expenditure, body mass index (BMI), body fat mass, and visceral fat mass, with clinically relevant variations in these outcomes. Conclusions: Variations in thyroid function within the laboratory reference range have clinically relevant correlations with resting energy expenditure, BMI, and body composition in L-T4–treated subjects. However, salutary effects of higher fT3 levels on energy expenditure may be counteracted by deleterious effects on body weight and composition. Further studies are needed before these outcomes should be used as a basis for altering L-T4 doses in L-T4–treated subjects.


Sign in / Sign up

Export Citation Format

Share Document